FDA, the time has long passed for Remestemcel-L to be approved. These poor kids deserve so, so much better. Not only do their bodies have to fight the disease but also the drug.
https://www.nature.com/articles/s41409-024-02252-z
- Forums
- ASX - By Stock
- Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
FDA, the time has long passed for Remestemcel-L to be approved....
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.8¢ |
Change
-0.038(3.77%) |
Mkt cap ! $1.124B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 95.0¢ | $1.451M | 1.488M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 110234 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 24362 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 112634 | 0.955 |
20 | 323873 | 0.950 |
10 | 111701 | 0.945 |
12 | 172292 | 0.940 |
10 | 535489 | 0.935 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 36477 | 25 |
0.965 | 35458 | 18 |
0.970 | 88532 | 10 |
0.975 | 78467 | 9 |
0.980 | 64276 | 4 |
Last trade - 13.19pm 20/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |